$338 Million is the total value of Nan Fung Group Holdings Ltd's 55 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 110.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NFH | NEW FRONTIER HEALTH CORP | $95,691,000 | +2.0% | 8,350,000 | 0.0% | 28.31% | -5.7% | |
| ILMN | ILLUMINA INC | $49,323,000 | -6.2% | 129,647 | 0.0% | 14.59% | -13.3% | |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | $32,778,000 | +11.2% | 768,708 | 0.0% | 9.70% | +2.8% | |
| KRTX | KARUNA THERAPEUTICS INC | $30,760,000 | +7.1% | 234,811 | 0.0% | 9.10% | -1.0% | |
| SOMALOGIC INC | $19,748,000 | -6.1% | 1,696,558 | 0.0% | 5.84% | -13.2% | ||
| New | EXSCIENTIA PLCads | $15,219,000 | – | 770,200 | +100.0% | 4.50% | – | |
| EAR | EARGO INC | $14,722,000 | -24.2% | 2,886,724 | 0.0% | 4.36% | -30.0% | |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $8,816,000 | +26.4% | 210,563 | +31.4% | 2.61% | +16.8% |
| RANI THERAPEUTICS HLDGS INC | $8,070,000 | -8.3% | 493,584 | 0.0% | 2.39% | -15.2% | ||
| SGEN | New | SEAGEN INC | $7,010,000 | – | 45,340 | +100.0% | 2.07% | – |
| XENE | XENON PHARMACEUTICALS INC | $6,182,000 | +104.4% | 197,880 | 0.0% | 1.83% | +88.9% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $5,718,000 | -61.3% | 1,166,952 | 0.0% | 1.69% | -64.2% | |
| BEAM | BEAM THERAPEUTICS INC | $4,375,000 | -8.4% | 54,903 | 0.0% | 1.29% | -15.4% | |
| NFHWS | NEW FRONTIER HEALTH CORP*w exp 11/30/202 | $4,266,000 | -4.3% | 1,580,000 | 0.0% | 1.26% | -11.5% | |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $3,514,000 | – | 171,760 | +100.0% | 1.04% | – |
| BGNE | New | BEIGENE LTDsponsored adr | $3,036,000 | – | 11,205 | +100.0% | 0.90% | – |
| GRTX | GALERA THERAPEUTICS INC | $2,815,000 | -43.3% | 613,223 | 0.0% | 0.83% | -47.6% | |
| INCY | New | INCYTE CORP | $2,533,000 | – | 34,510 | +100.0% | 0.75% | – |
| NVTA | Buy | INVITAE CORP | $2,411,000 | -41.4% | 157,862 | +9.1% | 0.71% | -45.9% |
| OTIC | OTONOMY INC | $1,770,000 | +8.3% | 851,000 | 0.0% | 0.52% | +0.2% | |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $1,695,000 | – | 12,600 | +100.0% | 0.50% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $1,505,000 | – | 48,500 | +100.0% | 0.44% | – |
| EXAS | EXACT SCIENCES CORP | $1,359,000 | -18.5% | 17,464 | 0.0% | 0.40% | -24.7% | |
| EXEL | EXELIXIS INC | $1,174,000 | -13.5% | 64,200 | 0.0% | 0.35% | -20.0% | |
| SRRA | SIERRA ONCOLOGY INC | $1,152,000 | -0.8% | 52,979 | 0.0% | 0.34% | -8.3% | |
| KOD | New | KODIAK SCIENCES INC | $1,139,000 | – | 13,440 | +100.0% | 0.34% | – |
| KALV | KALVISTA PHARMACEUTICALS INC | $1,041,000 | -24.2% | 78,720 | 0.0% | 0.31% | -30.0% | |
| ALXO | ALX ONCOLOGY HLDGS INC | $902,000 | -70.9% | 41,950 | 0.0% | 0.27% | -73.1% | |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $818,000 | – | 35,035 | +100.0% | 0.24% | – |
| BLUE | New | BLUEBIRD BIO INC | $783,000 | – | 78,350 | +100.0% | 0.23% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $659,000 | – | 7,460 | +100.0% | 0.20% | – |
| STSA | SATSUMA PHARMACEUTICALS INC | $643,000 | -3.5% | 142,900 | 0.0% | 0.19% | -10.8% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $594,000 | -67.3% | 370,950 | 0.0% | 0.18% | -69.8% | |
| RUBY | RUBIUS THERAPEUTICS INC | $550,000 | -45.8% | 56,768 | 0.0% | 0.16% | -49.8% | |
| New | DICE THERAPEUTICS INC | $499,000 | – | 19,700 | +100.0% | 0.15% | – | |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $435,000 | – | 9,340 | +100.0% | 0.13% | – |
| New | SURROZEN INC | $419,000 | – | 65,070 | +100.0% | 0.12% | – | |
| ARGX | New | ARGENX SEsponsored adr | $396,000 | – | 1,130 | +100.0% | 0.12% | – |
| KYMR | New | KYMERA THERAPEUTICS INC | $315,000 | – | 4,960 | +100.0% | 0.09% | – |
| New | TANGO THERAPEUTICS INC | $279,000 | – | 25,500 | +100.0% | 0.08% | – | |
| MRTX | New | MIRATI THERAPEUTICS INC | $266,000 | – | 1,810 | +100.0% | 0.08% | – |
| PRLD | New | PRELUDE THERAPEUTICS INC | $253,000 | – | 20,350 | +100.0% | 0.08% | – |
| CNTA | New | CENTESSA PHARMACEUTICALS PLCsponsored ads | $250,000 | – | 22,200 | +100.0% | 0.07% | – |
| New | TSCAN THERAPEUTICS INC | $219,000 | – | 48,600 | +100.0% | 0.06% | – | |
| RETA | REATA PHARMACEUTICALS INCcl a | $218,000 | -73.8% | 8,265 | 0.0% | 0.06% | -75.6% | |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $215,000 | – | 15,545 | +100.0% | 0.06% | – |
| AMYT | New | AMRYT PHARMA PLCsponsored ads | $207,000 | – | 19,150 | +100.0% | 0.06% | – |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $193,000 | – | 11,445 | +100.0% | 0.06% | – |
| ABCL | New | ABCELLERA BIOLOGICS INC | $188,000 | – | 13,180 | +100.0% | 0.06% | – |
| LIFE | New | ATYR PHARMA INC | $176,000 | – | 23,500 | +100.0% | 0.05% | – |
| SYBX | SYNLOGIC INC | $166,000 | -20.6% | 68,634 | 0.0% | 0.05% | -26.9% | |
| KURA | New | KURA ONCOLOGY INC | $163,000 | – | 11,650 | +100.0% | 0.05% | – |
| DYN | DYNE THERAPEUTICS INC | $138,000 | -27.0% | 11,629 | 0.0% | 0.04% | -31.7% | |
| VINC | New | VINCERX PHARMA INC | $113,000 | – | 11,050 | +100.0% | 0.03% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $94,000 | – | 27,925 | +100.0% | 0.03% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -3,470 | -100.0% | -0.02% | – |
| FLNT | Exit | FLUENT INC | $0 | – | -194,800 | -100.0% | -0.14% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 10 | Q3 2023 | 34.7% |
| HARMONY BIOSCIENCES HLDGS IN | 10 | Q3 2023 | 21.3% |
| XENON PHARMACEUTICALS INC | 10 | Q3 2023 | 3.1% |
| BOLT BIOTHERAPEUTICS INC | 10 | Q3 2023 | 5.6% |
| GALERA THERAPEUTICS INC | 10 | Q3 2023 | 1.9% |
| KALVISTA PHARMACEUTICALS INC | 10 | Q3 2023 | 1.8% |
| EXELIXIS INC | 10 | Q3 2023 | 1.1% |
| DBV TECHNOLOGIES S A | 10 | Q3 2023 | 0.6% |
| ALX ONCOLOGY HLDGS INC | 10 | Q3 2023 | 1.0% |
| ILLUMINA INC | 9 | Q3 2023 | 21.5% |
View Nan Fung Group Holdings Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eargo, Inc. | December 16, 2022 | 2,958,099 | 0.7% |
| Stealth BioTherapeutics Corp | January 09, 2020 | 20,240,817 | 4.8% |
| New Frontier Health Corp | January 02, 2020 | 9,650,000 | 7.3% |
View Nan Fung Group Holdings Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-16 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Nan Fung Group Holdings Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.